DSIP Nasal Spray (5mg)

Research Overview

A nonapeptide first isolated in 1974 from the cerebral venous blood of rabbits during induced slow-wave sleep. DSIP promotes delta-wave (deep) sleep patterns without the sedative effects of GABAergic sleep aids, and has additional roles in stress response and pain modulation.

Origin: Isolated from cerebral venous blood of rabbits during slow-wave sleep (1974)

Mechanism of Action

• Delta-wave sleep promotion

• Cortisol modulation

• LH release modulation

• Somatostatin interaction

• Endorphin system modulation

Primary Research Areas

• Sleep architecture

• Insomnia

• Stress-related sleep disturbance

• Circadian regulation

• Pain modulation

Key Published Findings

• Promoted delta-wave sleep in EEG studies without next-day sedation

• Normalized disturbed sleep patterns in chronic insomnia models

• Reduced ACTH and cortisol levels during stress in animal models

Research Protocol

Commonly studied routes: Subcutaneous, Intranasal. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.

Storage

-20°C lyophilized

Important Notice

DSIP Nasal Spray (5mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.